Seòmar agus comataidhean

The overall financial model, is a commercial negotiation between Global Energy Group and Haizea Wind Group, but I can confirm that Haizea has received no public funding. This government is supportive of the efforts by Global Energy Group, owners of the port of Nigg to strengthen our domestic supply chain capacity, by developing manufacturing facilities at the port. Working alongside our Enterprise Agencies, we are committed to ensuring our supply chain is given all available opportunities to capitalise on the growth of the offshore renewables sector, sustaining existing skilled jobs and delivering new ones. The priority now for Global Energy Group is to develop a revised business case which continues with the aim to deliver a world class manufacturing facility at Nigg. This business case will of course take into account a revised financial model, both private sector and public sector funding and will seek to set out revised milestones with a target of delivering towers.

The Housing for Varying Needs design guide offers good practice in the design of homes in order to help them achieve a degree of flexibility, suit people of varying needs, be convenient to use, and be fit for purpose. Where possible, all new affordable homes delivered through the Affordable Housing Supply Programme are built to Housing for Varying Needs standards.

As set out within the Housing to 2040 route map, we are reviewing the Housing for Varying Needs design guide. We want the guide to help better meet the needs of an ageing population, help people to live in their home for longer, consider a wider range of needs, and learn lessons from the pandemic by recognising the importance of outdoor space, and space for home working or study.

We plan to consult on proposed changes to the guide over the coming months and will wish to engage with disability groups and those with experience of living in homes delivered to Housing for Varying Needs standards, as well as those involved in the delivery of new homes.

Once complete, the review of Housing for Varying Needs will inform the introduction of building standards in 2025-26 to underpin a new Scottish Accessible Homes Standard, which all new homes will need to achieve, regardless of tenure.

The Scottish Government does not hold this information centrally. The particular circumstances and needs in terms of social work input of each Cystic Fibrosis patient and their family can be highly variable. The Scottish Government therefore expects NHS Boards and Local Authority partners delivering care to work together to support Cystic Fibrosis patients according to individual need.

COVID-19 vaccines are recommended in pregnancy. Vaccination is the best way to protect against the known risks of COVID-19 in pregnancy for both women and babies.

NHS inform have a dedicated page for pregnancy and the COVID-19 vaccine. Details on how pregnant people book their COVID-19 vaccines/booster can be found here www.nhsinform.scot/covid19vaccinepregnancy

The Scottish Government Marketing Team are continuing to promote vaccine uptake in pregnancy and if planning a pregnancy through a targeted marketing campaign. The COVID-19 vaccine explainer video also covers pregnancy and is available in a range of different community languages. More information can also be found in the above link.

I refer the member to the answer to question S6W-09460 on 13 July 2022. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

The Heart Disease Action Plan (2021), sets out a strategic vision to ensure that everyone with suspected heart disease in Scotland has equitable access to timely and evidence-based diagnosis, treatment and care. Priority 2 in the plan contains a focus on improving access to diagnostics, including imaging.

There are no Scottish Intercollegiate Guidelines Network (SIGN) guidelines for takotsubo cardiomyopathy. The decision to create, update and/or replace any SIGN guideline is made independently by the Evidence Directorate Work Programme Committee in Healthcare Improvement Scotland (HIS). Any group or individual can propose a guideline topic to SIGN. Guideline topics are selected on the basis of burden of disease, the existence of variation in practice, and the potential to improve outcomes.

Chief Scientist Office (CSO) is not currently directly funding research into Takotsubo Cardiomyopathy, though there is an active programme of research into this condition led by the University of Aberdeen. This research has taken place with Scotland-wide recruitment of participants with the support of NHS Research and Development which is funded by CSO.

The following table shows the number of properties purchased in the last 5 years in each category under the Open Market Shared Equity scheme. This information is voluntarily provided by the purchaser and in some cases, purchasers may fall into more than one category.

COVID-19 vaccines are recommended in pregnancy. Vaccination is the best way to protect against the known risks of COVID-19 in pregnancy for both women and babies.

Public Health Scotland have created animations for minority ethnic audiences which include information on vaccinations and pregnancy. These videos, information and other assets are shared routinely with partners representing minority ethnic communities in Scotland for cascading.

Our COVID-19 vaccine explainer video also covers pregnancy and is available in a range of different community languages.

COVID-19 vaccine pop-up clinics have been held in maternity clinics in a number of health boards. This allows people to get vaccinated in a safe and trusted space, after having any concerns or questions answered by an expert health practitioner.

The Scottish Government Marketing Team are continuing to promote vaccine uptake in pregnancy and if planning a pregnancy through a targeted marketing campaign. To find out more visit www.nhsinform.scot/covid19vaccinepregnancy

The information requested is not yet publically available.

Scotland’s first three Early Cancer Diagnostic Centres (ECDC) are pilots to help inform wider roll-out of an optimal model for patients with non-specific symptoms suspicious of cancer.

All three Centres are using a nationally agreed minimum data-set, capturing patient identifiable data locally. A sub-section of this data will be published by the three Boards later this Summer to mark one-year since the early adopter sites were established.

Meanwhile, work is underway with Public Health Scotland to scope and progress the national data collection of ECDCs as more sites are expected to come on-stream.

Through the ClimateXChange centre of expertise the Scottish Government has received expert advice on the use of animal feed additives which have the potential to reduce methane emissions. This advice has suggested that more data are needed to assess the full potential of feed additives and feed materials in reducing methane emissions from livestock.

FSS and FSA are responsible for assessing animal feed safety in GB. Any new innovative feed material would be considered through the feed risk analysis process. For feed additives these are products that require to be authorised by the GB regulated product process before they can be sold and used in animal feed in GB and may only be used for the purpose stated in the authorisation. The FSA and FSS carry out the risk analysis process for regulated products such as feed additives and provide advice to Ministers who decide whether the product can be placed on the market in England, Wales and Scotland. Feed additives intended to reduce methane production in ruminants are new and highly innovative feed additives and within the GB regulated products application process are being categorised and risk assessed as; zootechnical feed additives under the functional group ‘as substances which favourably affect the environment’.